EGFR and neoplasm: EGFR expression by tumour cells was detected byimmunohistochemistry in 36 out of the 42 (86%) valuable patients with MPNST;percentages were higher in the NF1 subgroup (95% versus 75%; P = .06; Chisquare test) (see Table 1).